Pillstats
Rx only · Tablet, For Suspension · Oral

Deferasirox

Brands: Exjade · Deferasirox

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US35 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)614373
US makers11 labelers
Packages62
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1903795697592025 Q12025 Q22025 Q32025 Q42026 Q1
556
Rx · 2026 Q1
37K
Units dispensed
+1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novadoz Pharmaceuticals LLCunknown12SUPPLYING
MSN Laboratories Private Limitedunknown12SUPPLYING
Dr.Reddy's laboratories Limitedunknown9SUPPLYING
Alembic Pharmaceuticals Limitedunknown6SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown6SUPPLYING
Bionpharma Inc.unknown3SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
Novartis Pharmaceuticals Corporationunknown3SUPPLYING
Ascend Laboratories, LLCunknown3SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown3SUPPLYING
Actavis Pharma, Inc.unknown2EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 20, 2023
    RECALLRecall (Class II): Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals In…

    Failed Dissolution Specifications — Recalling firm: Glenmark Pharmaceuticals Inc., USA — USA nationwide